Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2025-12-24 @ 2:24 PM
NCT ID:
NCT02712359
Eligibility Criteria:
Inclusion Criteria:
* Subjects whose parent(s)/ LAR(s), in the opinion of the investigator, can and will comply with the requirements of the protocol.
* Written informed assent/consent obtained from the subject or subject's parent(s)/ LAR(s) of the subject.
* Available HAV vaccination records.
* Children who have received either 1 or two doses of Havrix at selected health centres of Panama.
* Children with ≥ 7 years and \< 10 years between last dose and Persistence Visit 1 (Year 8) and children ≥ 10 years and \< 13 years between last dose and Persistence Visit 1' (Year 10).
Exclusion Criteria:
* Child in care.
* Subjects with history of vaccination with other hepatitis A vaccines other than Havrix.
* Subjects with known past history of hepatitis A infection, both without vaccination and after they received the last dose of Havrix (1 dose or the complete 2 dose schedule).
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
15 Years
Study:
NCT02712359
Study Brief:
Protocol Section:
NCT02712359